1
Eijsink, Job F. H., Al Khayat, Mohamed N. M. T., Boersma, Cornelis, ter Horst, Peter G. J., Wilschut, Jan C., Postma, Maarten J.
Veröffentlicht in: Eijsink , J F H , Al Khayat , M N M T , Boersma , C , ter Horst , P G J , Wilschut , J C & Postma , M J 2021 , ' Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands ' , European Journal of Health Economics , vol. 22 , no. 1 , pp. 75-88 . https://doi.org/10.1007/s10198-020-01236-2;
2021
Veröffentlicht in: Eijsink , J F H , Al Khayat , M N M T , Boersma , C , ter Horst , P G J , Wilschut , J C & Postma , M J 2021 , ' Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands ' , European Journal of Health Economics , vol. 22 , no. 1 , pp. 75-88 . https://doi.org/10.1007/s10198-020-01236-2;
2021
2
Urbanus, Anouk T., van Keep, Marjolijn, Matser, Amy A., Rozenbaum, Mark H., Weegink, Christine J., van den Hoek, Anneke, Prins, Maria, Postma, Maarten J.
Veröffentlicht in: Urbanus , A T , van Keep , M , Matser , A A , Rozenbaum , M H , Weegink , C J , van den Hoek , A , Prins , M & Postma , M J 2013 , ' Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective? ' , PLoS ONE , vol. 8 , no. 8 , e70319 . https://doi.org/10.1371/journal.pone.0070319;
2013
Veröffentlicht in: Urbanus , A T , van Keep , M , Matser , A A , Rozenbaum , M H , Weegink , C J , van den Hoek , A , Prins , M & Postma , M J 2013 , ' Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective? ' , PLoS ONE , vol. 8 , no. 8 , e70319 . https://doi.org/10.1371/journal.pone.0070319;
2013
3
de Vries, Folgerdiena M., Denig, Petra, Visser, Sipke T., Hak, Eelko, Postma, Maarten J.
Veröffentlicht in: de Vries , F M , Denig , P , Visser , S T , Hak , E & Postma , M J 2014 , ' Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands ' , Value in Health , vol. 17 , no. 2 , pp. 223-230 . https://doi.org/10.1016/j.jval.2013.12.010;
2014
Veröffentlicht in: de Vries , F M , Denig , P , Visser , S T , Hak , E & Postma , M J 2014 , ' Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands ' , Value in Health , vol. 17 , no. 2 , pp. 223-230 . https://doi.org/10.1016/j.jval.2013.12.010;
2014
4
Setiawan, Didik, Luttjeboer, Jos, Westra, Tjalke Arend, Wilschut, Jan C., Suwantika, Auliya A., Daemen, Toos, Atthobari, Jarir, Wilffert, Bob, Postma, Maarten J.
Veröffentlicht in: Setiawan , D , Luttjeboer , J , Westra , T A , Wilschut , J C , Suwantika , A A , Daemen , T , Atthobari , J , Wilffert , B & Postma , M J 2015 , ' The cost-effectiveness of HPV vaccination in addition to screening : a Dutch perspective ' , Expert review of vaccines , vol. 14 , no. 4 , pp. 589-604 . https://doi.org/10.1586/14760584.2014.990386;
2015
Veröffentlicht in: Setiawan , D , Luttjeboer , J , Westra , T A , Wilschut , J C , Suwantika , A A , Daemen , T , Atthobari , J , Wilffert , B & Postma , M J 2015 , ' The cost-effectiveness of HPV vaccination in addition to screening : a Dutch perspective ' , Expert review of vaccines , vol. 14 , no. 4 , pp. 589-604 . https://doi.org/10.1586/14760584.2014.990386;
2015